Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Market Cap	1.88B +10.6%
Revenue (ttm)	193.90M -16.5%
Net Income	4.82M -51.4%
EPS	2.01 -51.4%
Shares Out	2.40M
PE Ratio	390.04
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	Nov 23, 2025

Volume	1,186
Average Volume	1,373
Open	799.00
Previous Close	792.90
Day's Range	780.00 - 799.00
52-Week Range	681.00 - 947.90
Beta	-0.39
RSI	69.81
Earnings Date	Jan 21, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 474
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In fiscal year 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.